Other chest
the Jarvik artificial heart has been used most often. Of 84 implanted devices, 7i have been Jarvik models [3] . To study the radiographic appearance of the device and its thoracic complications, we reviewed the chest radiographs of seven patients who received a Jarvik heart at the University of Arizona.
Materials and Methods
A Jarvik total artificial heart device (Symbion Inc., Salt Lake City, UT) consists of two independent ventricles, each with a pneumatically driven diaphragm. After the ventricles are filled with blood from the native right and left atria, the diaphragms are driven upward like pistons by extracorporeal pneumatic pumps, ejecting blood into the systemic and pulmonary circulations ( Fig. 1) . Figure 2 is a radiograph of the Jarvik heart showing its structural components. to the extracorporeal pneumatic pumps by reinforced polyurethane tubes that enter through the anterior chest wall. They are inflated and deflated by controlled pulses of air such that the stroke volumes of the ventricles can be varied to meet the circulatory needs without changing the heart rate, thus responding to changes in cardiac preload as a normally functioning human heart responds. The ventricular pumping chambers of the Jarvik heart are positioned one behind the other and have a distinctive radiographic appearance.
Dunng diastole, the blood chambers are filled and only a crescent of air is visible in the air chambers (Fig. 3) . On a radiograph obtained during systole, the air chambers are completely distended (Fig. 4) . resolve after implantation could be considered a complication.
AteleCtasis
As with heart and heart-lung transplantation patients, recipients of artificial heart devices exhibit left lower lobe atelectasis after surgery. This is often difficult to appreciate on anteroposterior chest radiographs alone, because of the overlying density of the device (Fig. 5) , necessitating lateral or oblique films for evaluation. All seven of our patients exhibited some degree of left lower lobe atelectasis after surgery. In four patients, the atelectatic changes did not resolve despite aggressive respiratory therapy. Persistent atelectasis in these patients was believed to be caused by mechanical impact of the device against the left lower lobe due to imperfect fit of the device within the chest. If the device is well positioned and appropriately sized, atelectasis due to compression from mechanical action of the artificial heart should be minimal.
Pulmonary Edema
Preimplant pulmonary edema in artificial heart recipients is usually severe and after implantation may persist until extravascular fluid is mobilized. Even in uncomplicated postoperative courses, pulmonary edema persisted for 3-6 days after implantation.
Pulmonary edema was clinically severe in three patients, with mechanical ventilation being required for 7-31 days after surgery. Radiographically, diffuse alveolar infiltrates were present. In the other four patients, postoperative pul- 
A B
AJR:1 51, October1988
JARVIK ARTIFICIAL HEART IMPLANT 669 monary edema was clinically less severe and radiographically manifested as hilar and basilar infiltrates. These patients were weaned from the ventilator in 1-3 days.
In order to enhance mobilization of pulmonary fluid, a diastolic vacuum of up to 7 mm Hg is produced by the Jarvik extracorporeal pump system to lower mean right and left atrial pressures. The use of diastolic suction with Jarvik heart devices has the advantage of increasing ventricular filling without volume loading or raising atnal pressures, thereby assisting with diuresis of retained fluid. 
Major Vascular Compression
Persistent pulmonary edema more severe in the left lung despite the use of ventricular diastolic vacuum indicated obstruction of the left pulmonary veins in one patient. The cause of obstruction was the disproportionate size of the implant relative to the size of the patient's thoracic cage (Fig.  6) . Placement of struts between the sternal edges to enlarge the thoracic cavity in order to alleviate compression of the pulmonary veins was not successful and the patient died.
In a second patient, progressive lower extremity edema, hepatosplenomegaly, and ascites prompted transfemoral yenous catheterization, which revealed a 10-mm gradient across the diaphragmatic portion of the inferior vena cava. Relief of compression was accomplished by repositioning the device farther to the left.
Malfunction of the Mechanical Heart
In one of the patients, a left atrial catheter resulted in left inflow ("mitral") valve regurgitation that necessitated removal of the catheter. This was evident on the chest radiograph as worsening pulmonary edema. and disseminated herpes simplex. At the time of a subsequent heart transplant, infection around the device was well evaluated with CT (Fig. 7) .
Mediastinal Bleeding
Because patients are anticoagulated to prevent thrombotic and embolic events, sequential chest radiographs are important to detect bleeding complications.
Progressive postoperative mediastinal widening was seen in one patient who developed atrial tamponade from hemorrhage into the pencandium around the device, necessitating surgical drainage.
Fibrous Adhesions
Development of fibrous adhesions between the device and pleural surfaces can cause air leaks, leading to pneumothorax on pneumopenicandium (Fig. 7) . Mechanical motion of the artificial ventricles and adherent fibrous tissue may cause shearing of small distal airways, resulting in air leaks. An airfilled ventricular chamber must not be mistaken for a loculated pneumothorax.
In the patient with the longest-term implant (243 days), removal of the artificial heart before transplantation of a donor heart was difficult because of formation of dense fibrous adhesions around the device and between the device and the left lung.
Discussion
In the last 20 years, more than $200 million has been invested in artificial hearts, of which the Jarvik heart is now the most widely used. Its development has been well chronicled by previous investigators [1 -3] . With few exceptions, the primary use of artificial hearts is as a temporary measure.
Currently designed artificial heart devices do not conform well to the shape or size of the pericardial space. Their position is influenced by the shape and dimensions of the thorax. Ideally, the device is positioned in the penicardium so that the left ventricle is inferior, lateral, and posterior to the right ventricle.
This helps prevent obstruction of the pulmonary veins and venae cavae. The distance between the sternum and the vertebral bodies is the major limiting factor in obtaining fit without venous compression. Careful preoperative evaluation of the recipient's thoracic volume is necessary. Currently, the bulkier 100-mI Jarvik-7 device is used only in patients weighing more than 75 kg and in those with a sternalvertebral distance of at least 13 cm [4, 5].
Artificial hearts are now being used successfully as a temporary measure until a donor heart is available for transplantation. Permanent implantable artificial hearts may someday be available for older patients with irreparable heart damage who may not qualify for transplantation and for patients eligible for transplantation who may die before a suitable donor heart is found. In such cases, the mechanical heart will serve as a "bridge to life." The Jarvik heart serves that purpose today when successful transplantation can follow.
